Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia

Journal: Cell

Published: 2018-05-31

DOI: 10.1016/j.cell.2018.05.013

Affiliations: 12

Authors: 25

Go to article
Institutions FC
Center for Cellular Immunotherapies (CCI), Penn, United States of America (USA) 0.30
NIH NHLBI Hematology Branch, United States of America (USA) 0.22
Department of Pathology and Laboratory Medicine, Penn, United States of America (USA) 0.08
Department of Hematology, St. Jude, United States of America (USA) 0.08
Division of Hematology and Oncology, Penn Medicine, United States of America (USA) 0.06
OSU Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), United States of America (USA) 0.06
Mayo Clinic Department of Hematology, United States of America (USA) 0.04
Graduate Group in Genomics and Computational Biology, Penn, United States of America (USA) 0.04
NIH Department of Laboratory Medicine, United States of America (USA) 0.04
Frederick National Laboratory for Cancer Research (FNLCR), United States of America (USA) 0.04
Department of Biochemistry and Molecular and Cellular Biology, Georgetown University, United States of America (USA) 0.02
OSU Division of Hematology, United States of America (USA) 0.02

Return